StonvexLoading…
StonvexStonvexStonvexCore line items from EHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.59B | $5.94B | $4.39B | $2.91B |
Operating Income | $288.70M | $953.00M | $695.30M | $475.40M |
Net Income | $194.50M | $566.20M | $420.10M | $293.60M |
EPS (Diluted) | $1.93 | $5.54 | $4.11 | $2.87 |
Total Assets | $7.31B | $7.09B | $6.87B | $6.79B |
Total Liabilities | $3.95B | $3.81B | $3.68B | $3.70B |
Cash & Equivalents | $110.50M | $72.20M | $48.70M | $99.10M |
Free Cash Flow OCF − CapEx | $150.70M | $439.20M | $322.50M | $238.80M |
Shares Outstanding | 100.60M | 102.20M | 102.30M | 102.20M |